Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BJDX |
---|---|---|
09:32 ET | 13191 | 1.1585 |
09:34 ET | 2000 | 1.1533 |
09:41 ET | 400 | 1.1585 |
09:52 ET | 300 | 1.16 |
09:57 ET | 2000 | 1.1501 |
10:06 ET | 600 | 1.15 |
10:08 ET | 1514 | 1.15 |
10:14 ET | 7516 | 1.15 |
10:19 ET | 1150 | 1.14 |
10:21 ET | 2000 | 1.1309 |
10:26 ET | 1500 | 1.1301 |
10:28 ET | 308 | 1.14 |
10:32 ET | 1200 | 1.148 |
10:33 ET | 500 | 1.1307 |
10:37 ET | 700 | 1.135 |
10:39 ET | 3430 | 1.13 |
11:06 ET | 4460 | 1.1301 |
11:15 ET | 300 | 1.13 |
11:20 ET | 1379 | 1.13 |
11:36 ET | 100 | 1.1294 |
11:42 ET | 230 | 1.1292 |
11:49 ET | 100 | 1.13 |
11:51 ET | 150 | 1.125 |
11:58 ET | 1700 | 1.1296 |
12:00 ET | 300 | 1.1299 |
12:02 ET | 151 | 1.1246 |
12:34 ET | 200 | 1.1256 |
12:38 ET | 8627 | 1.1201 |
01:35 ET | 100 | 1.11 |
01:53 ET | 244 | 1.1199 |
02:08 ET | 5000 | 1.129 |
02:15 ET | 477 | 1.1299 |
02:24 ET | 288 | 1.12 |
02:29 ET | 500 | 1.1288 |
02:44 ET | 1400 | 1.1128 |
02:47 ET | 1000 | 1.1188 |
03:21 ET | 300 | 1.1293 |
03:38 ET | 4237 | 1.1272 |
03:39 ET | 150 | 1.1289 |
03:45 ET | 100 | 1.125 |
03:56 ET | 2102 | 1.12 |
03:57 ET | 100 | 1.125 |
03:59 ET | 807 | 1.12 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bluejay Diagnostics Inc | 22.6M | -2.8x | --- |
PetVivo Holdings Inc | 21.5M | -3.9x | --- |
RenovoRx Inc | 23.8M | -2.6x | --- |
REMSleep Holdings Inc | 25.8M | -2.9x | --- |
Wearable Health Solutions Inc | 25.2M | 0.0x | --- |
Femasys Inc | 24.7M | -2.9x | --- |
Bluejay Diagnostics, Inc. is engaged in the developing medical diagnostics tests devices. The Company offers diagnostic testing in infectious, inflammatory and metabolic diseases by using its Symphony platform. Symphony platform is an automated diagnostic system, consisting of a fluorescence immuno-analyzer which uses a single-use diagnostic test cartridge with reagents integrated in the cartridge. The Company is developing a pipeline of diagnostic tests for Symphony, including triage of myocardial infarction (MI), congestive heart failure (CHF), neutropenic sepsis in cancer, and other disease diagnostic indications using the same Symphony platform. The Company's Symphony IL-6 product candidate is for early and rapid identification of sepsis during Emergency Department (ED), critical care triage, and neutropenic sepsis in oncology patients. Symphony IL-6 product candidate is also for monitoring disease progression during such treatment regimen.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.6M |
---|---|
Revenue (TTM) | $249.0K |
Shares Outstanding | 20.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.41 |
Book Value | $1.01 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 90.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,561.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.